Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.51, $0.37 better than the analyst estimate of $0.14. Revenue for the quarter came in at $277 million versus the consensus estimate of $254.41 million.

GUIDANCE:

Omnicell sees Q3 2024 EPS of $0.34-$0.44, versus the consensus of $0.40. Omnicell sees Q3 2024 revenue of $275-285 million, versus the consensus of $277.1 million.

Omnicell sees FY2024 EPS of $1.20-$1.50, versus the consensus of $1.11. Omnicell sees FY2024 revenue of $0.775-0.875 billion, versus the consensus of $1.06 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.